Gulfo Might Reevaluate Negotiated User Fees If Selected US FDA Commish

Joseph Gulfo, a former medtech industry CEO and vocal FDA critic, is the latest candidate apparently being considered for FDA commissioner. In an interview with Medtech Insight, he outlines his worldview and interest in pushing aggressively against increasing the FDA "body of law."

More from Regulation

More from Policy & Regulation